Trial ID or NCT#

NCT01759511

Status

NOT RECRUITING

Purpose

This study is to evaluate the long term safety and tolerability of simtuzumab (GS-6624) in participants with Idiopathic Pulmonary Fibrosis (IPF) who had previously participated in Gilead clinical trial AB0024-201.

Investigator(s)

Kapilkumar Patel

Contact us to find out if this trial is right for you.

CONTACT

Susan Jacobs
(650) 725-8083